volume 87, issue 3, P270-271 2010
DOI: 10.1038/clpt.2009.292
View full text
|
|
Share

Abstract: Selection of a drug dose in pediatrics is generally based on no or incomplete pharmacokinetic data. Traditionally, allometric, or scaling, techniques have been used; however, they have inherent limitations and may not make optimal use of the drug-specific clinical pharmacokinetic information that is available. Modeling is a tool that holds promise. The future challenge is to create a structured approach to determining pediatric doses for new therapeutic agents.

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
29
0

Publication Types

Select...

Relationship

0
0

Authors

Journals